{
  "paper_metadata": {
    "pmid": "38157332",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on a BRCA2 pathogenic variant associated with breast cancer in a Down syndrome patient."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.2097 del",
      "protein_notation": null,
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "35-year-old female with Down syndrome",
        "phenotype": "Invasive ductal carcinoma of the breast"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 35,
          "age_at_onset": null,
          "age_at_diagnosis": 35,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Invasive ductal carcinoma of the breast",
          "evidence_sentence": "Testing for a BRCA mutation was thought to be necessary for determining the need for second-line chemotherapy. BRCA analysis (Myriad Genetics) detected a BRCA2 pathogenic variant (c.2097 del); hence, olaparib was orally administered 15 months after the initiation of the first-line chemotherapy."
        }
      ],
      "functional_data": {
        "summary": "The BRCA2 variant is associated with defective DNA double-strand repair, leading to increased cancer risk.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "This is the first reported case of breast cancer harboring a germline BRCA2 pathogenic variant in a patient with Down syndrome.",
      "key_quotes": [
        "This report highlights a rare case of primary breast cancer harboring a germline BRCA2 pathogenic variant in an individual with DS."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper provided clear information regarding the BRCA2 variant."
  }
}